Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>Breast intraductal papilloma is a heterogeneous group. The aim of the study is to investigate the intraductal breast papilloma and its coexisting lesions retrospectively in real‐world practice.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>We retrospectively identified 4450 intraductal breast papilloma and its coexisting lesions.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>About 18.36% of intraductal papilloma coexisted with malignant lesions of the breast, 37.33% coexisted with atypia hyperplasia (AH), 25.24% coexisted with benign lesions, and only 19.10% coexisted without concomitant lesions. In addition, 36.80% of intraductal breast papilloma had nipple discharge, 51.46% had a palpable breast mass, and 16.45% had both nipple discharge and a palpable breast mass. About 28.18% experienced discomfort or were asymptomatic. Furthermore, 98.99% had ultrasound abnormalities, and 53.06% had intraductal hypoechogenicity upon ultrasound. 31.89% had mammographic distortion, and 14.45% had microcalcification upon mammography. Intraductal breast papilloma with malignancy had significant correlations with clinical manifestations.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusion</h3><p>Coexisting malignancy was also related to ultrasound abnormality (BIRADS 4C and 5), mammographic distortion, and microcalcification upon mammography but was not related to the intraductal hypoechoic upon ultrasound. Coexisting atypical hyperplasia correlated with nipple discharge but not palpable mass, mammographic distortion, or intraductal hypoechoic upon ultrasound. The coexisting AH was also related to abnormality upon ultrasound or microcalcification compared with the benign lesions. The intraductal papilloma coexists with malignancy or AH accounted for more than 50%, and the clinical information on papilloma and its coexisting lesions is nonspecific. We recommended surgical treatment for benign intraductal papillary lesions.</p></section>

Diagnosis and Differential Diagnosis of Intraductal Papillary Adenoma of Breast, Atypical Papilloma and Intraductal Papillary Carcinoma

MRI and the Pathology of Breast Invasive Micropapillary Carcinoma

Immunohistochemical Study of Intraductal Papilloma Neoplasms of the Breast

Morphologic changes of breast carcinoma after neoadjuvant therapy and its differential diagnosis

Breast Adenomyoepithelioma: a Clinicopathological Observation and Review of Literature

A retrospective observational study of intraductal breast papilloma and its coexisting lesions: A real‐world experience

[Clinicopathologic Study of Intracystic Papillary Carcinoma of the Breast].

Clinical Analysis of the Intraductal Papillomatosis of Breast ( A Report of 27 Cases )

Progress in Pathological Diagnosis of Intraductal Papillary Mucinous Neoplasm of the Pancreas

Adenomyoepithelioma of breast: a clinicopathological analysis

Solid papillary carcinoma of breast:a clinicopathologic study of 73 case

Clinical Analysis of 151 Patients with Carcinomatous Change of Breast Intraductal Papilloma

[Clinicopathologic Study of Breast Cancer with Features of Endocrine Ductal Carcinoma-in-situ].

Invasive papillary carcinoma of the breast

[Diagnosis and Differential Diagnosis of Intraductal Papillary Mucinous Neoplasm of Pancreas].

Sonographic Features of Benign Intraductal Papillary Lesions of Breast

Ribosomes of rat liver catalyze ‘minimal’ donor reaction

Solid intraductal papilloma of breast: Some characteristics on sonogram

Intraductal Papilloma with Benign Pathology on Breast Core Biopsy: To Excise or Not?

The Clinicopathologic Features of 22 Cases With Primary Invasive Papillary Carcinoma of the Breast Identified in 1153 Cases With Invasive Breast Carcinoma: Single-Center Experience

The clinicopathologic features of intraductal papillary mucinous neoplasms of the pancreas